Millions of Patients, Hundreds of Patents, Over $6 Billion in Medical Device Sales.

And After Decades of Innovation, We’re Only Getting Started.

Millions of Patients, Hundreds of Patents, Over $6 Billion in Medical Device Sales.

And After Decades of Innovation, We’re Only Getting Started.

Syntheon, Innovative Ideas to Improve Medical Care

We’re proud of our achievements that have created enduring partnerships with many of the world’s most admired companies. From Boston Scientific to Johnson & Johnson and many more, with a century of product development experience Syntheon principals are fundamentally improving medical care. Our success only reaffirms our quest for innovative products and partnerships, understanding that what’s good for patients is also good business – and this builds long-term value for all stockholders. 52+ Million Patients, 200+ Patents and over $6 Billion in Sales.

November 27th, 2023

Medtronic adds innovative Penditure™ Left Atrial Appendage Exclusion System to Cardiac Surgery portfolio

The Penditure™ Left Atrial Appendage Medtronic plc, a global leader in healthcare technology, today announced the launch of its Penditure™ Left Atrial Appendage (LAA) Exclusion System in the United States. The Penditure LAA Exclusion System is an innovative, implantable clip that comes pre-loaded on a single-use delivery system for use in left atrial appendage management (LAAM) during concomitant cardiac surgery procedures. The Penditure clip is curved to better match the atrial anatomy1 and was designed without fabric for atraumatic closure and reduced inflammation.2 The Penditure device is the only LAA clip that can be recaptured, repositioned, and redeployed after deployment during a procedure, putting greater control in the hands of surgeons.3 

 

Medtronic completed the acquisition of the Penditure device technology from Syntheon LLC in August 2023. The acquisition expands the company’s Cardiac Surgery product portfolio to include left atrial appendage management. The first cases were performed by Drs. Gorav Ailawadi and Basel Ramlawi at the University of Michigan Frankel Cardiovascular Center and Lankenau Heart Institute, part of Main Line Health, respectively.

 Read More

Leveraging Engineering and Expertise To Create Tomorrow’s Medical Devices

Our Incubator Model Drives Proven Results!

Partner with us to bring the next
great medical care innovation to market.

Partner with us to bring the next great medical care innovation to market.

52+ Million Patients | 200+ Patents | Over $6 Billion in Sales

Decades Partnering With Industry Leaders.

Ethicon

Edwards Lifesciences

Covidien

Medtronic

Boston Scientific